From Medscape Diabetes & Endocrinology

Coverage from the

Obesity Week 2024

November 03 - 06, 2024; San Antonio, Texas

November 03 - 06, 2024 San Antonio, Texas

Conference News

Obesity Week 2024 Semaglutide 2.4 mg Could Cut Medical Costs for Some
Medscape Medical News, November 14, 2024
Obesity Week 2024 Weight Loss Treatments Beyond the Reach of Many in Need
Medscape Medical News, November 13, 2024
Obesity Week 2024 Oral Semaglutide 25-mg Dose May Provide Most Benefit
Medscape Medical News, November 11, 2024
Obesity Week 2024 Do Patients on Anti-Obesity Drugs Decrease Alcohol Use?
Medscape Medical News, November 8, 2024
Obesity Week 2024 Knowledge Gaps About Obesity Medicine Seen in Primary Care
Medscape Medical News, November 6, 2024

Obesity Week 2024 Early-Life Sugar Restriction Reduces T2D, Hypertension Risk
Medscape Medical News, November 6, 2024
Obesity Week 2024 Tirzepatide Slashes Progression From Prediabetes to T2D
Medscape Medical News, November 5, 2024
Obesity Week 2024 Coming Soon: A New Disease Definition, ‘Clinical Obesity’
Medscape Medical News, November 5, 2024
Obesity Week 2024 Semaglutide 2.4 mg Reduces All-Cause Hospital Admissions
Medscape Medical News, November 4, 2024
Obesity Week 2024 Obesity Week 2024 Tackles Treatment, Prevention and Access
Medscape Medical News, October 29, 2024

Medscape Diabetes©

Popular News From Obesity Week 2023

Beyond Semaglutide, a Coming Pipeline of New Antiobesity Meds With nutrient-stimulated hormone therapies for obesity in phase 3 trials, and activin-receptor inhibitors the next upcoming drug class, highly effective treatments for obesity are in sight.
Medscape Medical News, Oct 31, 2023
Antidepressants 'Don't Blunt' Semaglutide and Weight Loss Clinicians 'should be reassured' that patients with obesity and on antidepressants who don't have major depressive disorder or suicidality in the past 2 years can receive semaglutide, says a researcher.
Medscape Medical News, Oct 19, 2023
Newer Antiobesity Meds Lower the Body's Defended Fat Mass Newer antiobesity medications change the body's defended fat mass (set point) to something more normal, rather than "fixing" it at a lower target, which is a good thing, says a clinician.
Medscape Medical News, Nov 07, 2023

Previous Coverage

All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.